Clinical Trial Update: New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating a chemoimmunotherapy combination for systemic diffuse large B-cell lymphoma with CNS involvement. The study has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2025-07-08